| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |